ArticleJournal of enzyme inhibition and medicinal chemistry2026
Optimisation and mechanistic characterization of a selective benzoxazine-based MAP4K4 inhibitor in pancreatic cancer cells.
Yi-Wen Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.